Original article title
NaV1.8 Inhibition and the Future of Nonopioid Analgesia in Otolaryngology: A Narrative Review.
Takeaway
Suzetrigine offers a nonopioid pain-treatment mechanism and has beaten placebo in abdominoplasty and bunionectomy trials. This review finds ENT-specific evidence still limited, so whether it meaningfully reduces opioid exposure after head-and-neck procedures remains uncertain.
Keep in mind
Narrative review; limited ENT-specific clinical evidence.
pubmed.ncbi.nlm.nih.gov · Full-text access depends on the publisher.
The takeaway was checked against source text. The original title is preserved above.
This is a reading aid. Follow the source for methods, limitations, corrections, and clinical context.